Table 2.
Prevalence and Adjusted Associations with Belief That Nicotine Directly Contributes to Development of Birth Defects, CVD, Cancer, and COPD (N = 1020)
| Birth defects | CVD | Cancer | COPD | |||||
|---|---|---|---|---|---|---|---|---|
| % | APR (95% CI) | % | APR (95% CI) | % | APR (95% CI) | % | APR (95% CI) | |
| Gender | ||||||||
| Female | 36.3% | 1.28 (1.07, 1.54) | 81.4% | 0.97 (0.92, 1.03) | 78.7% | 0.97 (0.91, 1.03) | 78.5% | 0.96 (0.90, 1.02) |
| Male | 27.6% | Referent | 85.9% | Referent | 82.9% | Referent | 84.1% | Referent |
| Age | ||||||||
| 5 years | - | 0.91 (0.88, 0.96) | - | 0.99 (0.98, 1.00) | - | 0.99 (0.98, 1.00) | - | 0.99 (0.98, 1.01) |
| Specialty | ||||||||
| Cardiology | 36.8% | 1.78 (1.26, 2.50) | 86.8% | Referent | 82.6% | 1.08 (0.95, 1.22) | 81.9% | 1.20 (1.06, 1.37) |
| Family medicine | 36.1% | 1.63 (1.18, 2.24) | 88.6% | 1.01 (0.93, 1.09) | 87.1% | 1.13 (1.01, 1.26) | 87.6% | 1.27 (1.13, 1.43) |
| Internal medicine | 39.6% | 1.86 (1.35, 2.57) | 81.7% | 0.94 (0.85, 1.04) | 82.9% | 1.08 (0.96, 1.21) | 83.5% | 1.22 (1.08, 1.38) |
| OB/GYN | 21.4% | Referent | 87.6% | 1.00 (0.92, 1.09) | 83.1% | 1.08 (0.97, 1.21) | 85.1% | 1.25 (1.11, 1.40) |
| Oncology | 30.9% | 1.34 (0.93, 1.93) | 80.2% | 0.93 (0.83, 1.03) | 77.2% | Referent | 76.5% | 1.12 (0.98, 1.29) |
| Pulmonary | 32.4% | 1.42 (1.01, 1.99) | 73.4% | 0.84 (0.75, 0.94) | 68.2% | 0.89 (0.78, 1.02) | 68.2% | Referent |
Prevalence ratios are adjusted for all variables in table and race/ethnicity (NH Black, Hispanic, NH Asian, NH other/unknown vs. NH White). We excluded 38 participants with missing responses for one or more analysis variables
CVD, cardiovascular disease; COPD, chronic obstructive pulmonary disease; APR, adjusted prevalence ratio; CI, confidence interval